BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38893607)

  • 1. Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys
    Mazlan MZ; Wan Azman WN; Yaacob NM; Koon TS; Yahya NK
    Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O; Salvagno GL; Gelati M; Lippi G
    Pract Lab Med; 2016 Dec; 6():8-13. PubMed ID: 28856208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical and clinical performance of the Advansure i3 procalcitonin assay.
    Heo W; Park HD
    Scand J Clin Lab Invest; 2021 Nov; 81(7):546-551. PubMed ID: 34601986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM; Bargnoux AS; Montagnon V; Kuster N; Badiou S; Cristol JP
    Scand J Clin Lab Invest; 2020 Nov; 80(7):541-545. PubMed ID: 33124916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C; Shuster A; Weber C; Gebhardt K; Scheidegger M; Swartzwelder J; Williams J; Li J
    Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Procalcitonin Assays on KRYPTOR and LIAISON
    Dipalo M; Gnocchi C; Avanzini P; Musa R; Di Pietro M; Aloe R
    Diagnostics (Basel); 2019 Aug; 9(3):. PubMed ID: 31398868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M; Guido L; Micca G; Pittalis S; Locatelli M; Motta A; Bianchi V; Callegari T; Aloe R; Da Rin G; Lippi G
    Pract Lab Med; 2015 Aug; 2():22-28. PubMed ID: 28932801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new sensitive automated assay for procalcitonin detection: LIAISON
    Fortunato A
    Pract Lab Med; 2016 Dec; 6():1-7. PubMed ID: 28856207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Demonte D; Faggian D; Plebani M
    Diagnostics (Basel); 2020 Feb; 10(3):. PubMed ID: 32111028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and Sensitive Lateral Flow Immunoassay Method for Procalcitonin (PCT) Based on Time-Resolved Immunochromatography.
    Shao XY; Wang CR; Xie CM; Wang XG; Liang RL; Xu WW
    Sensors (Basel); 2017 Feb; 17(3):. PubMed ID: 28264502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Lo Cascio C; Demonte D; Faggian D; Plebani M
    Clin Chem Lab Med; 2019 Dec; 58(1):77-84. PubMed ID: 31539351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A; Binder L; Clough M; Hernandez MH; Lefèvre G; Mostert K; Nguyen TB; Otte KM; Portakal O; Sandri MS; Yen JL; Huang J; Beshiri A
    Pract Lab Med; 2018 Nov; 12():e00110. PubMed ID: 30519621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor.
    Ceriotti F; Marino I; Motta A; Carobene A
    Clin Chem Lab Med; 2017 Nov; 56(1):162-169. PubMed ID: 28809746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Different Blood Sample Types on Quantitative Detection of Procalcitonin.
    Sheng H; Zhang X; Peng Z; Chen F
    Clin Lab; 2022 Feb; 68(2):. PubMed ID: 35142184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
    Wang G; Wan Y; Lin G; Li Z; Dong Z; Liu T
    J Immunol Methods; 2020; 484-485():112829. PubMed ID: 32673618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay.
    Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP
    Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.
    Eidizadeh A; Wiederhold M; Schnelle M; Binder L
    Pract Lab Med; 2022 May; 30():e00274. PubMed ID: 35465623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.